Randomized Controlled Trial
Respiratory syncytial virus and recurrent wheeze in healthy preterm infants.
N. Engl. J. Med. 2013 May 9; 368 (19): 179117991791-9.
Randomized Controlled Trial
Ethical considerations and rationale of the MAKI trial: a multicenter double-blind randomized placebo-controlled trial into the preventive effect of palivizumab on recurrent wheezing associated with respiratory syncytial virus...
Contemp Clin Trials. 2012 Nov 1;33(6):1287-92.
Review
Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.
Health Technol Assess. 2008 Dec 1;12(36):iii, ix-x, 1-86.